
---
title: '患关节炎猫咪福音 美国批准首个控制疼痛抗体药物'
categories: 
 - 新媒体
 - 快媒体
 - 首页更新
headimg: 'https://www.kuai.media/news/2022/01/15/static/image/kuai/external-link.gif'
author: 快媒体
comments: false
date: 2022-01-15 04:10:59
thumbnail: 'https://www.kuai.media/news/2022/01/15/static/image/kuai/external-link.gif'
---

<div>   
<a href="https://www.kuai.media/go.php?aid=330874" target="_blank" role="link" data-focusable="true" class="sum" rel=" noopener noreferrer">

<strong>摘要</strong>: 受关节炎所苦的年长猫咪有福了，美国食品暨药物管理局（FDA）今天批准首个用于控制猫咪骨关节炎疼痛疗法，这也是第一个批准用在动物的单株抗体药物。法新社报导，实验室培养的单株抗体因被用于避免染疫的高风险患者发展为重症，而在疫情期间受人瞩目。但并非所有单株抗体药物都是用来对抗病原体，一些被批准用在癌症患者身上的单株抗体可标记癌细胞，以便免疫系统更容易辨认癌细胞并对抗它们。Today, FDA approved the first treatment to control pain in cats with osteoarthritis. This is also the first monoclonal antibody new animal drug approved by the FDA for use in any animal species. https://t.co/oeX5iA2Uxk pic. ... <span class="more"><img width="35" src="https://www.kuai.media/news/2022/01/15/static/image/kuai/external-link.gif" referrerpolicy="no-referrer">点击阅读全文 @cna.com.tw</span>
</a>


  
</div>
            